Related Experiment Videos
Evidence-based analysis: postoperative gastric bleeding: etiology and prevention
Jade S Hiramoto1, Jonathan P Terdiman, Jeffrey A Norton
1Department of Surgery, University of California, 533 Parnassus Ave Room U-372, San Francisco, CA 94143-7088, USA.
Surgical Oncology
|April 12, 2003
Summary
Stress-related gastric bleeding is a significant risk for cancer surgery patients. Intravenous proton pump inhibitors show promise for preventing bleeding in high-risk individuals.
Area of Science:
- Gastroenterology
- Surgical Oncology
- Critical Care Medicine
Background:
- Stress-related gastric bleeding is a critical concern in cancer patients undergoing major surgery, contributing to morbidity and mortality.
- While declining, its prevention is crucial, yet optimal pharmacologic strategies remain unclear.
Purpose of the Study:
- To review current recommendations and emerging evidence for stress ulcer prophylaxis (SUP) in surgical cancer patients.
- To compare the efficacy and safety profiles of different pharmacologic agents used for SUP.
Main Methods:
- Literature review of studies on stress ulcer prophylaxis in surgical patients.
- Analysis of clinical trial data comparing Histamine-2 receptor antagonists, sucralfate, and proton pump inhibitors.
Main Results:
- Histamine-2 receptor antagonists and sucralfate reduce clinically significant gastric bleeding.
- Sucralfate has fewer side effects like nosocomial pneumonia but may be less effective than H-2 blockers.
- Proton pump inhibitors demonstrate high efficacy and a favorable side effect profile, despite higher costs.
Conclusions:
- Prophylaxis is recommended for surgical patients with prolonged mechanical ventilation or coagulopathy.
- Intravenous proton pump inhibitors are suggested as the preferred agents for SUP in high-risk surgical cancer patients due to their effectiveness and safety.